Skip to content

Arthritis Health Journal Proof of Concept Study

Proof of Concept Study of the Arthritis Health Journal, a Patient Passport for Rheumatoid Arthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01941433
Acronym
AHJ
Enrollment
95
Registered
2013-09-13
Start date
2013-09-30
Completion date
2016-02-29
Last updated
2018-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

rheumatoid arthritis, self-management, online, patient passport

Brief summary

The purpose of this study is to determine whether an online patient passport tool called the Arthritis Health Journal can assist people with rheumatoid arthritis in managing their disease.

Detailed description

Patient passports have been developed and used in chronic diseases, such as diabetes, to promote active involvement of patients in their care, and have led to better treatment and health outcomes. In rheumatoid arthritis (RA), active involvement of patients in monitoring their symptoms and their disease activity may facilitate treatment according to current recommendations, which emphasize the need for aggressive treatment to suppress inflammation and for using a Treat to Target approach where treatment is escalated until a target is reached and is promptly modified when target is no longer met. In this study, the investigators have developed an online tool that aims to help people with RA monitor their symptoms and their disease activity and self-manage their arthritis. The investigators will perform a proof of concept study assessing how the Arthritis Health Journal affects consumer effectiveness, patient self-efficacy, communication with health professionals, shared decision-making, and satisfaction with medical care. The investigators will also evaluate the feasibility and satisfaction with using the Arthritis Health Journal. The investigators will use a stepped wedge study design, in which 50 participants will be randomized to either the intervention group (immediate use of the Arthritis Health Journal) or the control group (waitlisted for 6 months). Due to the nature of the intervention, the study is not blinded.

Interventions

BEHAVIORALArthritis Health Journal

Sponsors

Canadian Initiative for Outcomes in Rheumatology Care
CollaboratorOTHER
Vancouver Coastal Health
CollaboratorOTHER_GOV
Provincial Health Services Authority British Columbia
CollaboratorOTHER
University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be 18 years of age or older * Have a diagnosis of rheumatoid arthritis * Be under the ongoing care of a rheumatologist * Be comfortable using a computer and online applications * Have access to an Internet connection * Be able to read and write English without needing a translator

Exclusion criteria

* Younger than 18 years of age; * Diagnoses of arthritis other than rheumatoid arthritis * not under the ongoing care of a rheumatologist * not comfortable using a computer * lack of Internet access * inability to read and write in English without a translator

Design outcomes

Primary

MeasureTime frameDescription
Self-Management Behaviours6 monthsWe will use the overall score from the Partners in Health Scale, an 11 item questionnaire based on the principles of self-management, which measures people's ability to engage in behaviours for the self-management of a chronic disease.

Secondary

MeasureTime frameDescription
Self-Efficacy6 monthsWe will use the Stanford Self-Efficacy Scale to measure patient's confidence in their ability to perform certain actions to manage their disease and cope with the consequences of their disease. Specifically we will include the Manage Arthritis Symptoms, Manage Disease in General, and Communicate with Physician subscales.
Consumer Effectiveness6 monthsWe will use the Effective Consumer (EC-17) scale to measure patient's ability to deal with a chronic condition and make decisions about their health care. We will use the global EC-17 score, as well as results to individual questions (6, 7, 9, and 13) which were selected for their relevance to our intervention.
Patient Satisfaction with Care6 monthsWe will use the Patient Satisfaction Questionnaire to measure satisfaction with care and patient-physician interactions.
Self-Management Behaviours6 monthsWe will measure the results of individual questions 7 to 11 from the Partners in Health Scale, which specifically measure involvement in aspects of care relevant to our intervention.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026